Heart Disease News and Research

Latest Heart Disease News and Research

Discontinuation of statin therapy may benefit patients with terminal illness

Discontinuing statin use in patients with late-stage cancer and other terminal illnesses may help improve patients' quality of life without causing other adverse health effects, according to a new study by led by researchers at the University of Colorado Anschutz Medical Campus and Duke University and funded by the National Institute of Nursing Research (NINR).

24 Mar 2015

Study: Blood test can predict postoperative stroke risk following cardiac surgery

The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found.

24 Mar 2015

Home-exercise plan for HIV patients

In addition to antiretroviral medications, people with HIV may soon begin receiving a home exercise plan from their doctors, according to a researcher at Case Western Reserve University's Frances Payne Bolton School of Nursing.

24 Mar 2015

Low zinc levels in older adults correspond with increased chronic inflammation

Zinc, an important mineral in human health, appears to affect how the immune system responds to stimulation, especially inflammation, new research from Oregon State University shows.

23 Mar 2015

Using the butterfly effect to predict heart disease: an interview with Dr George and Dr Parthimos, Cardiff University

The emergence of the butterfly effect in many physical events reveals two fundamental laws that underpin all nonlinear systems. The first principle is known as determinism, which means that the evolution of an event can be followed accurately in the future, as long as we know its precise starting point and the rules of how a situation can change with time.

23 Mar 2015

Mast plans to develop vepoloxamer for chronic heart failure treatment

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its molecular adhesion and sealant technology (MAST) platform to develop novel therapies for sickle cell disease, arterial disease and heart failure, today announced its plans to develop vepoloxamer (MST-188) for the treatment of patients with chronic heart failure.

23 Mar 2015

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

Isis Pharmaceuticals, Inc. announced today positive results from a Phase 1 study with ISIS-ANGPTL3Rx. In this study, healthy volunteers treated with ISIS-ANGPTL3Rx achieved dose-dependent, statistically significant reductions in angiopoietin-like 3 (ANGPTL3) of up to 93 percent with a mean reduction of up to 84 percent from baseline (p<0.001).

23 Mar 2015

UM experts warn of serious risks associated with common IV devices

Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they're called, also raise the risk of potentially dangerous blood clots.

23 Mar 2015

Discovery can help stop emergence of age-related neurodegenerative diseases

As medicine has improved, increasing our ability to treat disease, so our longevity. The deterioration of the body with age, though, is a whole other matter.

23 Mar 2015

Copenhagen researchers develop secure way of measuring apo-M protein in human blood

Researchers from the University of Copenhagen are the first in the world to develop a secure way of measuring the important protein apo-M. This could prove relevant for research into diseases such as diabetes, arteriosclerosis and sclerosis.

23 Mar 2015

Study finds no statistical difference between CTA and functional stress tests

A new type of CT scan initially costs slightly less than the traditional stress test to diagnose blocked coronary arteries in patients with chest pain, but its lower cost did not translate into medical care savings over time, according to an analysis by Duke Medicine researchers.

23 Mar 2015

Anticoagulant drug bivalirudin shows mixed results in MATRIX trial

Patients with acute coronary syndrome undergoing angioplasty who received the anticoagulant drug bivalirudin did not show significant improvements in either of two co-primary endpoints--a composite of rate of death, heart attack or stroke at 30 days, or a composite of those events plus major bleeding--as compared to patients receiving standard anticoagulation therapy, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

23 Mar 2015

Using arm as access point for catheter-based heart procedures lowers risk of major bleeding, death

Patients with acute coronary syndrome undergoing coronary angiogram, a procedure used to assess blockages in the heart's arteries, had a significantly lower risk of major bleeding and death if their interventional cardiologist accessed the heart through an artery in the arm rather than the groin, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.

23 Mar 2015

Study: Blood tests for women taking spironolactone to treat hormonal acne are unnecessary

A new study by researchers at Brigham and Women's Hospital has found that for young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense.

23 Mar 2015

Experts call for global review of sepsis guidelines

Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.

22 Mar 2015

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Amgen today announced that an application seeking marketing approval of Repatha (evolocumab) for the treatment of high cholesterol has been submitted for review to the Ministry of Health, Labour and Welfare in Japan.

21 Mar 2015

Cosentyx (secukinumab) safe, effective for treating psoriasis patients

Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials.

21 Mar 2015

Royal Free London NHS Foundation Trust deploys OpenText to manage patient medical care records

OpenText, the global leader in Enterprise Information Management (EIM), today announced that the Royal Free London NHS Foundation Trust has implemented OpenText Content Suite to store and manage digitised copies of patient medical care records.

20 Mar 2015

Two-year data show continued survival advantage for self-expanding TAVR

Two-year data show a continued survival advantage for self-expanding transcatheter aortic valve replacement (TAVR) over standard surgery in high-risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology's 64th Annual Scientific Session.

20 Mar 2015

New anti-clotting therapy no better than established anticoagulants

A novel therapy that would allow doctors to turn the body's blood-clotting ability off and on in a more controlled way was about as effective as established anticoagulants in patients undergoing angioplasty but was associated with higher rates of moderate to severe bleeding, according to an analysis of data from a terminated Phase III trial presented at the American College of Cardiology's 64th Annual Scientific Session.

20 Mar 2015

Heart Disease News and Research

Latest Heart Disease News and Research

Discontinuation of statin therapy may benefit patients with terminal illness

Study: Blood test can predict postoperative stroke risk following cardiac surgery

Home-exercise plan for HIV patients

Low zinc levels in older adults correspond with increased chronic inflammation

Using the butterfly effect to predict heart disease: an interview with Dr George and Dr Parthimos, Cardiff University

Mast plans to develop vepoloxamer for chronic heart failure treatment

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

UM experts warn of serious risks associated with common IV devices

Discovery can help stop emergence of age-related neurodegenerative diseases

Copenhagen researchers develop secure way of measuring apo-M protein in human blood

Study finds no statistical difference between CTA and functional stress tests

Anticoagulant drug bivalirudin shows mixed results in MATRIX trial

Using arm as access point for catheter-based heart procedures lowers risk of major bleeding, death

Study: Blood tests for women taking spironolactone to treat hormonal acne are unnecessary

Experts call for global review of sepsis guidelines

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Cosentyx (secukinumab) safe, effective for treating psoriasis patients

Royal Free London NHS Foundation Trust deploys OpenText to manage patient medical care records

Two-year data show continued survival advantage for self-expanding TAVR

New anti-clotting therapy no better than established anticoagulants

Industry Focus eBook - Medical device (1st edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus eBook - Medical device (1st edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in